MDLN

Medline Inc. Class A Common Stock
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$48.38B
P/E Ratio
89.90
EPS
$0.40
Beta
—
52W High
$50.88
52W Low
$31.49
50-Day MA
$34.69
200-Day MA
$40.02
Dividend Yield
—
Profit Margin
2.32%
Forward P/E
20.92
PEG Ratio
—

About Medline Inc. Class A Common Stock

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$29.94B
Gross Profit (TTM)$7.51B
EBITDA$2.52B
Operating Margin0.82%
Return on Equity4.94%
Return on Assets2.46%
Revenue/Share (TTM)$34.14
Book Value$13.20
Price-to-Book2.60
Price-to-Sales (TTM)1.62
EV/Revenue1.338
EV/EBITDA14.57
Quarterly Earnings Growth (YoY)262.00%
Quarterly Revenue Growth (YoY)11.60%
Shares Outstanding$877.35M
Float$369.50M
% Insiders0.26%
% Institutions112.33%

Historical Volatility

HV 10-Day
18.20%
HV 20-Day
29.88%
HV 30-Day
36.28%
HV 60-Day
48.29%
HV Rank
—

Volatility is currently contracting

Analyst Ratings

Consensus ($44.42 target)
7
Strong Buy
16
Buy
4
Hold

Latest News

MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

GlobeNewsWire10/16/2026Neutral
$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

GlobeNewsWire10/14/2026Neutral
MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ: MDLN) for potential securities fraud after its significant stock drops.

PRNewsWire10/13/2026Neutral
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.

PRNewsWire10/12/2026Neutral
MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues

NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

GlobeNewsWire10/9/2026Neutral
MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations

New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp10/8/2026Neutral
MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

GlobeNewsWire10/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MDLN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026